BioSim considers that the INGESA specifications present some deficits in aspects that are "essential"

BioSim News

January 13, 2022BioSim News

The Spanish Association of Biosimilars - BioSim has a negative assessment of the specifications of the Framework Agreement for the purchase of biosimilars published by the National Institute of Health Management (INGESA), although it also maintains open to dialogue to find a point that allows the process to continue.

READ MORE

recently published

Post thumb
Informative breakfasts "Study on the market of biosimilar medicines in the National Health System in Spain"
March 18 2024
Post thumb
Horizon scanning
Jan 31 2024
Post thumb
Early Treatment: the role of biosimilars
18 2023 December
Post thumb
Study on the market for biosimilar medicines in the National Health System in Spain 2016-2022
18 2023 December

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

SUBSCRIBE